Abstract

CLC Number:

R994.11

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2017/V14/I3/189

[1] Caldemeyer L, Dugan M, Edwards J, et al. Long-Term Side Effects of Tyrosine Kinase Inhibitors Long-Term Side Effects of Tyrosine Kinase Inhibitors[J]. Curr Hematol Malig Rep, 2016, 11(2):71-79.
[2] Ureshino H, Nishioka A, Kojima K, et al. Subdural Hematoma Associated with Dasatinib and Intrathecal Methotrexate Treatment in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia[J]. Intern Med, 2016, 55(18): 2703-2706.
[3] OnoY, Mori T, Kato J, et al. Hemorrhagic colonic ulcers caused by dasatinib for chronic myelogenous leukemia [J]. Int J Hematol, 2010, 92(3): 556-558.
[4] Jasielec J K, Larson R A. Dasatinib-Related Pulmonary Toxicity Mimicking an Atypical Infection [J]. J Clin Oncol, 2016, 34(6): e46-e48.
[5] Kantarjian H M, Shah N P, Cortes J E, et al. Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)[J]. Blood, 2012, 119(5): 1123-1129.
[6] 徐晓俊, 孙春花. 达沙替尼致全身肌肉骨骼关节疼痛[J]. 药物不良反应杂志, 2009, 11(2): 133-134.
[7] 高习华. 达沙替尼致严重腹泻[J]. 药物不良反应杂志, 2011,13(3): 200.
[8] 陈燕琴, 丰明星, 韩娜, 等. 达沙替尼致严重胸腔积液1例[J].中南药学, 2014, 12(8): 831.
[9] 杨岚, 吕娜, 靖彧, 等. 达沙替尼治疗慢性髓系白血病导致乳糜胸3例[J]. 中国实验血液学杂志, 2016, 24(5): 1348-1353.
[10] 李骥, 赵慧慧, 李砚如, 等.达沙替尼导致1例Ph阳性急性淋巴细胞白血病可逆性肺动脉高压、胸腔积液、心包积液并文献复习[J]. 南京医科大学学报(自然科学版), 2016, 36(6): 764-768.
[11] Kimberlin D W, Rouse D J. Clinical practice Genital herpes[J]. N Engl J Med, 2004, 350(19): 1970-1977.
[12] Corey L, Adams H G, Brown Z A, et al. Genital herpes simplex virus infections: clinical manifestations, course, and complications[J]. Ann Intern Med, 1983, 98(6): 958-972.
[13] Rodriguez G H, Ahmed S I, Al-akhrass F, et al. Characteristics of, and risk factors for, infectionsin patients with cancer treated with dasatinib and a brief review of other complications [J]. Leuk Lymphoma, 2012, 53(8): 1530-1535.
[14] Yassin M A, Nashwan A J, Soliman A T, et al. Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy[J]. Clin Med Insights Case Rep, 2015, 8: 77-81.
[15] DavalosF, ChaucerB, ZafarW, et al. Dasatinib-Induced CMV Hepatitis in an Immunocompetent Patient: A Rare Complication of a Common Drug[J].Transl Oncol, 2016, 9(3): 248-250.
[16] R. Garcia-Mu?oz, E. Ruiz de Gaona, P. Rodriguez-Otero, et al.Reactivation of herpesvirus-6 in a chronic myeloyd leukemia (CML) patient during treatment with dasatinib[J]. Haematologica / The Hematology Journal, 2007, 92(s1): 493.
[17] MHRA. BCR-ABL tyrosine kinase inhibitors: risk of hepatitis B reactivation[EB/OL].(2016-05-10)[2017-01-24]. https://www.gov.uk/drug-safety-update/bcr-abl-tyrosine-kinase-inhibitors-risk-of-hepatitis-b-reactivation.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850.
[2]	WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.
[3]	XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862.
[4]	CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
[5]	CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882.
[6]	ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888.
[7]	SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895.
[8]	SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919.
[9]	YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
[10]	KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
[11]	LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
[12]	LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.
[13]	ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
[14]	ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943.
[15]	CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946.